Nephros (NEPH) Equity Average (2016 - 2025)
Historic Equity Average for Nephros (NEPH) over the last 15 years, with Q3 2025 value amounting to $9.8 million.
- Nephros' Equity Average rose 2177.02% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 2177.02%. This contributed to the annual value of $8.5 million for FY2024, which is 171.7% down from last year.
- As of Q3 2025, Nephros' Equity Average stood at $9.8 million, which was up 2177.02% from $9.4 million recorded in Q2 2025.
- In the past 5 years, Nephros' Equity Average ranged from a high of $15.6 million in Q1 2021 and a low of $8.0 million during Q3 2024
- For the 5-year period, Nephros' Equity Average averaged around $10.7 million, with its median value being $9.2 million (2022).
- As far as peak fluctuations go, Nephros' Equity Average surged by 4588.51% in 2021, and later crashed by 3862.16% in 2022.
- Nephros' Equity Average (Quarter) stood at $15.0 million in 2021, then crashed by 38.62% to $9.2 million in 2022, then fell by 8.03% to $8.5 million in 2023, then fell by 1.3% to $8.4 million in 2024, then increased by 16.98% to $9.8 million in 2025.
- Its last three reported values are $9.8 million in Q3 2025, $9.4 million for Q2 2025, and $8.9 million during Q1 2025.